Matritech, Inc.'s NMP22(R) BladderChek(R) Test Could Save Lives And Reduce Expense In Screening High Risk Populations For Bladder Cancer

Independent Study from University of Texas Southwestern Reports NMP22(R) BladderChek(R) Test could be Beneficial for Detecting Cancer Earlier in High Risk Populations.
MORE ON THIS TOPIC